Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant.
<h4>Purpose</h4>To determine the characteristics of diabetic macular edema (DME) patients refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone implant.<h4>Methods</h4>We classified 119 DME patients according to whether or not they are respon...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0222364 |